Navigation Links
Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
Date:11/10/2011

SAN DIEGO, Nov. 10, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported a summary of recent Company highlights and financial results for the third quarter and nine months ended September 30, 2011.

"We have made strong financial and operational progress in the first nine months of this year," said James E. Levine, President and Chief Executive Officer at Verenium. "In the third quarter of 2010 we shifted our business strategy toward growing a leading, commercial industrial enzymes business.  The continued increase in product revenue and record product gross profit we saw in the third quarter of 2011 are important indicators that we've had a solid year of progress against our new strategy and are well on our way to building a successful industrial biotechnology company."  

Company HighlightsSince the beginning of 2011, Verenium has made significant progress on both operational and financial fronts.  Recent accomplishments include:

Operational/Industry Performance:

Animal Health and Nutrition

  • Revenue in this product line is flat year-to-date, with improved performance in the third quarter from stronger sales by our marketing partner, Danisco, now part of E. I. du Pont de Nemours and Company; and
  • Announced and continued to progress the strategic collaboration with Novus International Inc. to jointly develop and commercialize a suite of new animal health and nutrition enzyme products from Verenium's late-stage product pipeline.

  • Grain Processing

  • Grew 2011 year-to-date revenues from the Company's grain processing enzymes by 29% over the same period in 2010; and
  • Grew grain processing revenue to represent 29% of 2011 year-to-date produc
    '/>"/>

  • SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
    2. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
    3. Verenium Corporation to Announce Third Quarter 2008 Financial Results
    4. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
    5. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
    6. Verenium Announces First Commercial Cellulosic Ethanol Project
    7. Verenium Announces Organizational Changes
    8. Verenium Completes Amendment to 8% Senior Convertible Notes
    9. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
    10. Verenium Announces Reverse Stock Split to Take Effect September 9
    11. Verenium 1:12 Reverse Stock Split Takes Effect
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/19/2014)... CITY, Calif. , Dec. 19, 2014 Bina ... , USA) announced today that they have been acquired ... 1,2 is a privately held company that provides ... of next generation sequencing (NGS) data for the academic ... the Roche Sequencing Unit, and will continue to focus ...
    (Date:12/19/2014)... BioPlus Specialty Pharmacy ... has an expanded team of Regional Pharmaceutical Care ... prescriber offices in their regions, with specific areas ... a variety of Regional Pharmaceutical Care Liaisons specializing ... hepatitis C help prescribers understand all the new ...
    (Date:12/19/2014)... 2014 Ed Bilsky, Ph.D., vice president ... for Excellence in the Neurosciences (CEN), and professor of ... selected as a member of the prestigious Dana Alliance ... from Maine to receive this honor. , The ... by the Dana Foundation. Its mission is to ...
    (Date:12/19/2014)... In contrast to traditional LED lights where the ... uses proprietary LED technology to incorporate their spectra in ... is critical in low proximity installations. The Valoya L-series ... lifetime which is up to four times longer than ... cost was clearly higher when compared to traditional fluorescent ...
    Breaking Biology Technology:Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3
    ... WORCESTER, Mass., Oct. 11 Generex Biotechnology Corporation (Nasdaq: ... plans to initiate a rights offering of common stock and ... stockholders approve a reverse stock split at the reconvened special ... October 15, 2010.  The amount of the offering has not ...
    ... Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and... -- REYKJAVIK, Iceland, October 11, ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
    ... Oct. 8 IntegenX, Inc. (IXI) today announced ... by the Defense Threat Reduction Agency (DTRA) of ... an Integrated Sample-to-Sequence (ISS) system for rapid detection ... medically relevant bacteria and viruses, and emerging pathogens. ...
    Cached Biology Technology:Generex Plans Rights Offering to Stockholders Following Reverse Stock Split 2Generex Plans Rights Offering to Stockholders Following Reverse Stock Split 3Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 2Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 3Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 4Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 5Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 6Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 7Not Only Size Matters: Genetic Megastudies Draw Out Distinctions Between Obesity and Waist-Hip Ratio 8IntegenX Awarded DTRA Contract to Develop Pathogen Detection and Identification Platform 2
    (Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... Region 2015-2019"  report to their offering. ... is advances in technology. With continuous advances in ... to the latest standard that meets the needs ...
    (Date:12/10/2014)... RALEIGH, N.C. , Dec. 9, 2014  Valencell, ... announced it is seeing a staggering demand from its ... demand, the Company revealed, is not solely coming from ... industries as well. "A wearable is only ... a result, accuracy is the ultimate driver in long-term ...
    (Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
    Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
    ... A team of Michigan State University scientists ... uncovered the inner workings of a key iron-containing enzyme, ... or understand how enzymes repair DNA. Taurine/alpha-ketoglutarate ... is important in metabolism. Enzymes in this family repair ...
    ... could see humble cotton thread emerge as a core ... such as kidney failure and diabetes. In a ... and sewing needles to literally stitch,together the uniquely low-cost ... postage stamp. Microfluidic analytical devices, which have been ...
    ... A team of University of Wisconsin-Madison engineers has ... selectively converts gamma-valerolactone, a biomass derivative, into the ... process preserves about 95 percent of the energy ... and captures carbon dioxide under high pressure for ...
    Cached Biology News:MSU scientists unlock key enzyme using newly created 'cool' method 2How long is a piece of thread? Long enough to save a life 2New process yields high-energy-density, plant-based transportation fuel 2
    Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
    ...
    Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
    ... Hybridization Wash Pack provides optimized blocking ... Preparation Quality Clarifier: Ready-to-use wash solutions ... SigmaScreen(tm) APS Coated Slides for Microarrays ... Hybridization Blocking Buffer: 1L • Microarray ...
    Biology Products: